Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B.
Document Type
Article
Publication Date
1-2021
JAX Source
J Hepatol 2021 Jan; 74(1):245-6
Volume
74
Issue
1
First Page
245
Last Page
246
ISSN
1600-0641
PMID
33008623
DOI
https://doi.org/10.1016/j.jhep.2020.07.038
Recommended Citation
Wen Z,
Feng Y,
Yan X.
Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B. J Hepatol 2021 Jan; 74(1):245-6
COinS